Work

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Year: 2022

Type: article

Abstract: Adv. Sci. 2021, 8, 2101458 DOI: 10.1002/advs.202101458 In the original published article, the name of Jianlin Wang was spelt incorrectly. The updated author byline is shown above.

Source: Advanced Science

DOI: 10.1002/advs.202202572

Authors: Zhuangzhuang Zhang, Lijun Cheng, Qiongsi Zhang, Yifan Kong, Daheng He, Kunyu Li, Matthew Rea, Jianlin Wang, Ruixin Wang, Jinghui Liu, Zhiguo Li, Chongli Yuan, Enze Liu, Yvonne N. Fondufe‐Mittendorf, Lang Li, Tao Han, Chi Wang, Xiaoqi Liu

Institutions: University of Kentucky, Purdue University West Lafayette, Markey Cancer Center, The Ohio State University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,200

Funders: National Institutes of Health, National Cancer Institute

Awards: Treatment of Castration-resistant Prostate Cancer (CRPC), Enhancing anti-neoplastic activity of metformin in prostate cancer, University of Kentucky Markey Cancer Center – Cancer Center Support Grant, Overcoming Drug Resistance of Castration-Resistant Prostate Cancer, Improving chemotherapy of castration-resistant prostate cancer.

OpenAlex ID: W4285601970

FWCI: 0.319

Cites: 3

Cited by: 2

Related to: 10